DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Pollack Jr CV, Reilly PA, van Ryn J. et al.
Idarucizumab for dabigatran reversal - full cohort analysis.
N Engl J Med 2017;
377 (05) 431-441
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.